Jean-Jacques Garaud, MD Global Head Pharma ... - Roche
Jean-Jacques Garaud, MD Global Head Pharma ... - Roche
Jean-Jacques Garaud, MD Global Head Pharma ... - Roche
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Rheumatoid Arthritis: Not all patients respond to<br />
current therapy<br />
Gold standard therapy<br />
anti-TNF + MTX<br />
% ACR70 Responders<br />
Unmet Medical Need<br />
Only 1 of 3 patients receives<br />
significant benefit<br />
anti-TNF + MTX<br />
anti-TNF alone<br />
ACR 70=70% Improvement in:<br />
MTX alone<br />
Disease activity – patient<br />
Disease activity – physician<br />
Patient assessment of Pain<br />
Physical disability<br />
Acute phase reactants – CRP,ESR<br />
24
Change language